Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis

<em><strong>Objective(s):</strong></em> This study is aimed to design and synthesize a prodrug of 5-aminosalicylic acid and evaluate its ameliorative effect on experimental ulcerative colitis (UC).<br /><em><strong>Materials and Methods:</strong></e...

Full description

Bibliographic Details
Main Authors:	Yan Yan, FengLing Ren, Pengchong Wang, Ying Sun, Jianfeng Xing
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2019-12-01
Series:	Iranian Journal of Basic Medical Sciences
Subjects:	anti-inflammation colon targeting prodrug ulcerative colitis 5-aminosalicylic acid
Online Access:	http://ijbms.mums.ac.ir/article_13991_ec1426b3a12c5983ce67e6d78201083a.pdf

Similar Items

5-Aminosalicylic Acid-induced Myocarditis in a Patient with Atypical Ulcerative Colitis
by: Hyo Yeop Song, et al.
Published: (2022-01-01)

A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model
by: Yang Y, et al.
Published: (2018-12-01)

USE OF 5-AMINOSALICYLIC ACID FOR TREATMENT OF ULCERATIVE COLITIS IN DIFFERENT DOSAGE MODES
by: M. V. Shapina, et al.
Published: (2017-11-01)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
by: Jun Miyoshi, et al.
Published: (2018-10-01)

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
by: Shinta Mizuno, et al.
Published: (2020-01-01)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
by: Jun Xu, et al.
Published: (2018-06-01)

Aminosalicylates in inflammatory bowel disease
by: Vojislav N. Perisic
Published: (2013-10-01)

Efficacy of mesalazine at ulcerative colitis with nutritional failure
by: A. V. Korolyov, et al.
Published: (2024-03-01)

Management and treatment of distal ulcerative colitis
by: Andrea Calafiore, et al.
Published: (2013-12-01)

5-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case Report
by: Asuka Watanabe, et al.
Published: (2024-01-01)

Prospects of MMX Mesalazine in Routine Outpatient Treatment of Ulcerative Colitis
by: Yu. P. Uspenskiy, et al.
Published: (2022-03-01)

Synthesis, characterization and radical scavenging activity of aromatic amine conjugates of 5-aminosalicylic acid
by: K. Harveer,, et al.
Published: (2014-09-01)

A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer
by: Lin Chen, et al.
Published: (2021-10-01)

Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis—Results of a Randomized Controlled Trial
by: Jan Březina, et al.
Published: (2021-06-01)

Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study
by: Hanyang Lin, et al.
Published: (2022-03-01)

What strategies do ulcerative colitis patients employ to facilitate adherence?
by: Kawakami A, et al.
Published: (2017-01-01)

Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial
by: Zhaofeng Shen, et al.
Published: (2021-01-01)

5-Aminosalicylic Acid Chemoprevention in Inflammatory Bowel Diseases: Is It Necessary in the Age of Biologics and Small Molecules?
by: Hans Herfarth, et al.
Published: (2021-09-01)

Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
by: Tripathi K, et al.
Published: (2021-08-01)

Prodrug Integrated Envelope on Probiotics to Enhance Target Therapy for Ulcerative Colitis
by: Kun Zhang, et al.
Published: (2023-02-01)

Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis
by: Virginia Solitano, et al.
Published: (2020-09-01)

Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis
by: Wooseong Kim, et al.
Published: (2019-11-01)

Effectiveness of treatment of moderate ulcerative colitis with prolonged mesalazine in real clinical practice
by: O. V. Knyazev, et al.
Published: (2021-10-01)

Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
by: Kazuhiko Uchiyama, et al.
Published: (2023-08-01)

Surveillance for colorectal cancer and chemoprevention in ulcerative and Crohn's colitis: The need for clinical strategies to increase effectiveness
by: Affifa Farrukh, et al.
Published: (2019-10-01)

Promising effect of infliximab on the extent of involvement in ulcerative colitis
by: Peyman Adibi, et al.
Published: (2011-01-01)

N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis
by: Jaejeong Kim, et al.
Published: (2023-11-01)

Phospholipid-Based Prodrugs for Colon-Targeted Drug Delivery: Experimental Study and In-Silico Simulations
by: Milica Markovic, et al.
Published: (2019-04-01)

A Rare Presentation of Recurrent Diverticulitis in a Patient with Ulcerative Colitis
by: Carlos Perez Hernandez, et al.
Published: (2022-04-01)

Application of Prodrugs to Inflammatory Diseases of the Gut
by: Jeffrey L. Ebersole, et al.
Published: (2008-02-01)

Malignant perforation of sigmoid colon in long-standing ulcerative colitis
by: G K Adithya, et al.
Published: (2019-01-01)

Medicinal Flavor of Fecal Microbiota and Efficacies of Its Transplantation in Mice with Different Types of Ulcerative Colitis
by: Xiaofei MA, Jiali HU, Manman CUI, Wei GE, Suqin YANG, Chenghua DING, Leichang ZHANG
Published: (2022-05-01)

A Colon-Targeted Prodrug, 4-Phenylbutyric Acid-Glutamic Acid Conjugate, Ameliorates 2,4-Dinitrobenzenesulfonic Acid-Induced Colitis in Rats
by: Soojin Kim, et al.
Published: (2020-09-01)

Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy
by: Dagmar Schierová, et al.
Published: (2020-10-01)

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
by: Soo-Kyung Park, et al.
Published: (2022-09-01)

THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE
by: O. V. Knyazev, et al.
Published: (2018-01-01)

New Features of Molecular Diagnostics of Ulcerative Colitis
by: A.S. Volkov, et al.
Published: (2016-03-01)

Determination of 5-aminosalicylic acid in pharmaceutical formulations by square wave voltammetry at pencil graphite electrodes
by: Carolina V. Uliana, et al.
Published: (2010-01-01)

Signet ring cell carcinoma of the rectal stump in a known ulcerative colitis patient
by: Asmanaz Nadaf, et al.
Published: (2023-01-01)

Antioxidant and Anti-Inflammatory Effects of Gel and Aqueous Extract of Melilotus officinalis L. in Induced Ulcerative Colitis: A Rattus norvegicus Model
by: Ali Reza Safarpour, et al.
Published: (2015-06-01)